CLARITAS PHARMACEUTICALS

Instrument Inactif

Communiqués Claritas Pharmaceuticals Toronto S.E.

Actions

KLY

CA1806341071

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Claritas Pharmaceuticals : IIROC Trading Resumption - CLAS	18/08/21	AQ
Claritas Announces Proposed Financing with Obsidian Global GP, LLC, Receipt of Australian Tax Credit, and Start of Phase 1 Clinical Study of R-107	18/08/21	GL
Claritas Pharmaceuticals : IIROC Trading Halt - CLAS	18/08/21	AQ
Claritas Announces Grant of Stock Options to Directors and Officers	28/07/21	GL
Claritas Pharmaceuticals : Cites Data from Study Demonstrating Effectiveness of Nitric Oxide in Patients with Severe COVID-19 Pneumonia as Validation of the Company’s Nitric Oxide-Releasing Compound, R-107	26/07/21	AQ
Claritas Announces Additional Data in Validated Animal Model of PAH Demonstrating Ability of R-107 to Prevent, Treat, and Reverse Established Disease	21/07/21	GL
Claritas Announces Effective Date for Share Consolidation	20/07/21	GL
Claritas Pharmaceuticals : Announces Commitments from Company's Largest Shareholders to Vote for Approval of Share Consolidation	11/06/21	AQ
Claritas Announces Commitments from Company’s Largest Shareholders to Vote for Approval of Share Consolidation	10/06/21	GL
Claritas Announces Transfer of GVHD Program and Cancellation of Related Debt as Company Focuses on Nitric Oxide Therapeutics	01/06/21	GL
Claritas Pharmaceuticals : Announces Settlement of Debt Transaction	31/05/21	AQ
Claritas Pharmaceuticals Issues Letter to Shareholders	11/05/21	GL
Claritas Announces Agreement with CMAX Clinical Research for Phase 1 Clinical Study of R-107	21/04/21	GL
Claritas Announces Letter of Intent to Acquire Exclusive Worldwide Rights to Develop R-107 for PAH	14/04/21	GL

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Sécurisez et Augmentez les Rendements de vos Investissements grâce à l'Accompagnement de Nos Experts

Sécuriser mes Investissements

fermer